Last reviewed · How we verify
NCT03169179
Physical Activity Wearables in the Police Force: The PAW-Force Trial
NA trial testing Fitbit and Bupa Boost app in Physical Activity in 182 participants. Completed in 20 April 2018.
28 March 2018
Quick facts
| Lead sponsor | University of Exeter |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 182 |
| Start date | 19 April 2017 |
| Primary completion | 28 March 2018 |
| Estimated completion | 20 April 2018 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Fitbit and Bupa Boost app
Conditions studied
- Physical Activity — all drugs for Physical Activity →
- Health Behavior — all drugs for Health Behavior →
Sponsor
University of Exeter
Who can join
18 and older, any sex, with Physical Activity or Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Policing is an increasingly sedentary occupation and high levels of physical and psychological morbidities are reported by officers and staff. Wearable fitness technology may be a feasible intervention to promote physical activity and improve health. This study aims to assess the feasibility and acceptability of introducing wearable fitness technology (Fitbit™ activity monitors linked to the 'Bupa Boost' smartphone app) as a motivator for increasing physical activity within the police force. Additional aims are to and to assess the potential impact of the intervention on physical activity, sedentary time, health and wellbeing, stress, sickness absence and self-perceived productivity, and to explore which motivational strategies (e.g. individual goal-setting vs. social competitions) are most acceptable and potentially effective and for which groups of staff. A single-group, before and after, mixed methods exploratory trial will be conducted. Approximately 180 police officers and staff from two sites (Plymouth Basic Command Unit and North Dorset) will be recruited to take part. Participants will use the technology for 12 weeks initially followed by a further five months of optional use. A combination of questionnaire surveys, interviews and analysis of staff absence records will be used. Data will be collected pre-intervention, mid-intervention (6 weeks), post-intervention (12 weeks) and follow-up (8 months). Primary outcomes are change in objectively recorded step count, self-reported physical activity and sedentary time. Secondary outcomes include general health and wellbeing, perceived stress and productivity, sickness absence, engagement with the intervention and perceived usability and usefulness. This study will add to our understanding of the feasibility and acceptability of mobile fitness technology in a specific workplace setting, and inform a potential larger trial within the police force.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Physical Activity Wearables in the Police Force (PAW-Force) study: acceptability and impact.
Buckingham SA, Morrissey K, Williams AJ, Price L, et al · · 2020 · cited 10× · PMID 33143665 · DOI 10.1186/s12889-020-09776-1
Verify or expand the search:
- PubMed search for NCT03169179
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting
Other University of Exeter trials
Trials by the same sponsor.
- NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
- NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
- NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
- NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
- NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03169179 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Exeter
- Last refreshed: 30 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03169179.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing